|
|
|
|
| LEADER |
03429nam a22003495i 4500 |
| 001 |
978-3-642-95455-9 |
| 005 |
20191024051316.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1985 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642954559
|
| 024 |
7 |
|
|a 10.1007/978-3-642-95455-9
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Clinical Experiences with Budipine in Parkinson Therapy
|c edited by F. Gerstenbrand, Werner Poewe, G. Stern.
|
| 250 |
|
|
|a 1st ed. 1985.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 1985.
|
| 300 |
|
|
|a XI, 213 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a James Parkinson and the Treatment of His Disease -- Biochemical Neuropathology: A New Approach to Parkinson’s Disease -- Clinical Neurophysiology of Parkinson’s Disease -- Dopaminergic Agonists and Receptors: Their Relevance to the Treatment of Parkinson’s Disease -- Brain Dopaminergic Receptor Changes in Parkinson’s Disease in Relation to the Disease Process and Treatment -- Analysis of Akinesia -- Observations of Voluntarily Induced Automatic Motor Behaviour in Parkinsonism -- Significance of Mental Disorders in the Long-Term Treatment of Parkinson’s Disease -- Treatment of Parkinson’s Disease in Early and Late Phases -- Relevance of Dopaminergic Agonists and Antagonists to Parkinsonian Tremor -- Therapeutic Possibilities in On-Off Phenomena in Parkinson’s Disease -- Target and Additive Drugs in the Treatment of Parkinson’s Disease: A Pilot Study -- Pharmacologic Bases of Antiparkinsonian Therapy -- The Pharmacodynamics of Budipine on Central Neurotransmitter Systems -- Biochemical and Pharmacologic Aspects of the Mechanism of Action of Budipine -- Pharmacokinetics and Metabolism of Budipine in Animals and Humans -- Clinical Experience with Budipine in Parkinsonian Therapy -- Controlled Single-Blind Trial of Budipine. L-Dopa, and Amantadine in 102 Patients with Parkinson’s Disease -- Open Clinical Trial of Budipine in 25 Tremor-Dominant Parkinsonian Patients -- Effect of Budipine on Parkinsonian Tremor Resistant to Other Antiparkinsonian Medication -- Budipine: A New Chemical Substance in the Treatment of Parkinson’s Disease -- Observations on the Therapeutic Effect of Budipine on Parkinson’s Disease -- Long-Term Treatment with Budipine -- Budipine Treatment of Neuroleptic-Induced Parkinsonism -- Randomized Double-Blind Trial of Budipine and Biperiden in Patients with Neuroleptic Extrapyramidal Symptoms -- The Effect of Budipine on the Rheology of the Blood -- EMG and Computer Analysis of Patients with Tremor and Rigidity Under Budipine Therapy -- Vigilance Study Using Electrooculographic and Electroencephalographic Methods After Acute Budipine Administration in Healthy Subjects -- Budipine in the Treatment of Extrapyramidal Disorders Not Related to Parkinson’s Disease.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Biochemistry, general.
|
| 700 |
1 |
|
|a Gerstenbrand, F.
|e editor.
|
| 700 |
1 |
|
|a Poewe, Werner.
|e editor.
|
| 700 |
1 |
|
|a Stern, G.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-95455-9
|